Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Clin Transplant. 2019 Apr;33(4):e13496. doi: 10.1111/ctr.13496. Epub 2019 Mar 5.
Systemic right ventricular (RV) failure may progress necessitating referral for orthotropic heart transplantation (OHT). Pulmonary hypertension (PH) frequently coexists in adult congenital heart disease and can complicate the assessment for OHT.
Single-center case series of six patients (median age 34.9 years [IQR, 31.9-42.4]) with systemic RV physiology with PH referred for OHT evaluation from 2008 to 2017.
One-third (n = 6) of 18 patients with systemic RV physiology referred for OHT evaluation had pulmonary arterial hypertension (PAH) defined as mean pulmonary artery pressure (mPAP) > 25 mm Hg and pulmonary vascular resistance (PVR) > 3 Wood Units. Two of the six patients were considered OHT-ineligible due to PH and comorbidities. Of the remaining four, two had pre-capillary PH and underwent heart-lung transplant (HLTx). The other two demonstrated reversibility of PVR with vasodilator testing and underwent OHT alone, one of whom died post-transplant from PH crisis.
Pulmonary arterial hypertension is common in systemic RV patients referred for OHT. Systemic RV dysfunction places these patients at risk for post-capillary PH but pre-capillary PH can exist. Despite management with selective pulmonary vasodilators and afterload reduction, criteria for listing patients for HLTx vs OHT are not known and need further elucidation.
系统性右心室(RV)衰竭可能会进展,需要转诊进行心脏移植(OHT)。肺动脉高压(PH)在成人先天性心脏病中经常并存,并可能使 OHT 的评估复杂化。
对 2008 年至 2017 年期间因 OHT 评估而转诊的 6 例(中位数年龄 34.9 岁[IQR,31.9-42.4])伴有 PH 的系统性 RV 生理学患者进行单中心病例系列研究。
在 18 例因系统性 RV 生理学而转诊接受 OHT 评估的患者中,有 1/3(n=6)存在肺动脉高压(PAH),定义为平均肺动脉压(mPAP)>25mmHg 和肺血管阻力(PVR)>3 伍德单位。这 6 例患者中有 2 例因 PH 和合并症而被认为不适合 OHT。在其余的 4 例中,有 2 例为毛细血管前 PH,并进行心肺移植(HLTx)。另外 2 例通过血管扩张剂试验显示 PVR 可逆性,并单独进行 OHT,其中 1 例在移植后因 PH 危象死亡。
肺动脉高压在因 OHT 而转诊的系统性 RV 患者中很常见。系统性 RV 功能障碍使这些患者处于毛细血管后 PH 的风险中,但也可能存在毛细血管前 PH。尽管进行了选择性肺动脉扩张剂和后负荷降低治疗,但将患者列入 HLTx 与 OHT 名单的标准尚不清楚,需要进一步阐明。